•  

St. Michael’s Hospital

BlueDot, formerly BioDiaspora Inc., secures Series A with Horizons Ventures

Toronto-based commercial arm of BioDiaspora research program tracks global spread of infectious diseases in real-time; fourth MI company to reach Series A TORONTO (Dec. 2, 2014) — BlueDot, a Toronto-based social benefit corporation founded by Dr. Kamran Khan, an infectious disease physician and scientist, tracks and predicts the global spread of infectious diseases. Spun off from St. Michael’s Hospital in partnership with MaRS Innovation (and formerly known as BioDiaspora Inc.), BlueDot, has secured a Series A venture capital funding from Horizons Ventures. Funded ... Read more

Tech Transfer Central features MaRS Innovation’s partnership with St. Michael’s Hospital

Tech Transfer Tactics, the monthly newsletter for Tech Transfer Central.com, has published a feature highlighting MaRS Innovation's Technology Transfer & Scouting (MITTS) services to St. Michael's Hospital. The interview explores the increase in disclosures and commercial activity achieved after MaRS Innovation began offering technology transfer services to the hospital, and was triggered by a July profile published on MaRS Innovation's website describing the collaborative working relationship between the two organizations. The interview includes conversations with Sahail Shariff, commercialization manager in the MITTS division, ... Read more

BioDiaspora founder appears on CBC’s “The National” to discuss the Ebola crisis

Dr. Kamran Khan, founder of BioDiaspora, appeared on CBC's "The National" on September 23, 2014, as part of a health panel examining the current state of the Ebola outbreak in west Africa. CBC anchor Peter Mansbridge hosted the discussion. Watch the clip on CBC's website. BioDiaspora, spun off from St. Michael's Hospital in partnership with MaRS Innovation, developed an easy-to-access, web-based solution that generates and communicates customized, actionable intelligence about global infectious disease threats in real-time. (more…) Read more

MaRS Innovation and St. Michael’s Hospital revitalizing commercialization process

For principal investigators, a key component in taking their research ideas from the bench to the market is knowing what commercialization resources exist and when to use them. Through the MaRS Innovation's Technology Transfer & Scouting division (MITTS), manager Sahail Shariff is connecting with principal investigators (PIs) at St. Michael's Hospital in Toronto on the front-line to better understand and advance their research. Of the 180 PIs at the hospital, the majority are clinician scientists who spend a portion of their time caring for patients. In collaboration ... Read more

MaRS Innovation’s 2013 Top 10 List

2013 was an exceptional year for MaRS Innovation. Here are the top 10 news stories from our commercialization portfolio. 1. MaRS Innovation secures a $15 million CECR funding extension In January, MaRS Innovation was one of four Centres of Excellence for Commercialization and Research to be successfully extended by the Networks of Centres of Excellence of Canada. This achievement reflects and recognizes the quality of the startups and licensable technologies within the MaRS Innovation portfolio, as well as the rigour of its business model and the achievements of its ... Read more

Dr. Hofstein’s Op-Ed for The Hill-Times, “Biotechnology research: A knowledge economy”

This op-ed on Canadian biotechnology and the knowledge economy appeared in The Hill-Times (subscription required), Canada's politics and government newsweekly, September 9: Obesity, cancer, heart disease and stroke, diabetes, Parkinson’s disease, Alzheimer’s, or the more general stresses of an aging population: no matter which area of concern holds our collective gaze from moment to moment, improving health outcomes and healthcare is the No. 1 challenge for the world’s economy. Canada has the holistic approach and translational research necessary to address health care’s pervasive ... Read more

BioDiaspora predicts Hajj and Umrah as two key possible spread points for MERS coronavirus

BioDiaspora, a start-up company based on the research of company founder, Dr. Kamran Khan of St. Michael's Hospital, has identified two mass gatherings in the Islamic world as key possible spread points for the life-threatening MERS coronavirus, which emerged in the Middle East in early 2012. BioDiaspora's disease-tracking platform, which correlates uses global air traffic patterns to predict the international spread of infectious disease (as described in the original media release from St. Michael's Hospital): The first is umrah, a pilgrimage that can ... Read more

BioDiaspora among technologies redefining digital disease mapping

Dr. Kamran Khan, founder of BioDiapsora, was cited in a New York Times' Bits article on the Big Data solutions evolving to track the global spread of disease: "In New Tools to Combat Epidemics, the Key is Context." Amy O'Leary's article appeared as part of a special blog/supplement on June 19, 2013 (Big Data 2013). Here's an excerpt (links and emphasis ours): One of the doctors in the field who can benefit from these types of insights is Dr. Kamran Khan, an infectious disease ... Read more

Is screening air travellers effective in containing a pandemic?

Toronto Star covers Khan's new WHO paper on H1N1 outbreak Dr. Kamran Khan, founder of BioDiaspora and an infectious disease physician and scientist at St. Michael’s Hospital, is among the experts studying the emergence of the H7N9 bird flu outbreak in China and the new coronavirus in the Middle East and Europe. Global News National also covered this story on April 11, 2013. Watch Beatrice Politi and Carmen Chai's report, "Canadian scientists pioneer new formula in airport disease screening," on the Global website. The ... Read more

BioDiaspora Founder: Travellers unlikely to bring H7N9 bird flu to Canada

Dr. Kamran Khan, founder of BioDiaspora and an infectious disease physician and scientist at St. Michael's Hospital, is among the experts studying the emergence of the H7N9 bird flu outbreak in China. Jennifer Yang interviewed Khan in today's Toronto Star about the likelihood of the disease being easily transmitted from human to human or arriving in Canada, as SARS did in 2003. Here's an excerpt: “This isn’t necessarily an event that poses a significant risk to Canada, at least based on all the current ... Read more
Page 2 of 3123